Aardvark Therapeutics, Inc. Common Stock (AARD) vs Insight Molecular Diagnostics Inc. (IMDX)
A side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and Insight Molecular Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AARD
Aardvark Therapeutics, Inc. Common Stock
$5.04HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
IMDX
Insight Molecular Diagnostics Inc.
$3.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AARD vs IMDX
growth of $100 · dividends reinvested · last 2yAARD -63.5% (-39.6%/yr)IMDX +54.9% (+24.4%/yr)IMDX compounded faster over this window
AARD IMDX
AARD vs IMDX: by the numbers
- •AARD is the larger company ($110M vs $109M market cap).
- •Both run net losses; AARD's is the smaller (0.00% vs -2955.63% net margin).
Metrics side by side
Valuation
| Metric | AARD | IMDX |
|---|---|---|
| P/S ratio | N/A | 65.35 |
| P/B ratio | 1.47 | N/A |
Profitability
| Metric | AARD | IMDX |
|---|---|---|
| Gross margin | 0.00% | 11.17% |
| Operating margin | 0.00% | -754.08% |
| Net margin | 0.00% | -2955.63% |
| ROE | -93.44% | N/A |
| ROIC | -97.99% | -223.06% |
Growth (annualized)
| Metric | AARD | IMDX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 27.24% |
| Total return CAGR (5Y) | N/A | -44.39% |
Go deeper
Dig into the metrics
Aardvark Therapeutics, Inc. Common Stock ROEInsight Molecular Diagnostics ROEAardvark Therapeutics, Inc. Common Stock operating marginInsight Molecular Diagnostics operating marginAardvark Therapeutics, Inc. Common Stock revenue growthInsight Molecular Diagnostics revenue growthAardvark Therapeutics, Inc. Common Stock free cash flowInsight Molecular Diagnostics free cash flow
Aardvark Therapeutics, Inc. Common Stock & Insight Molecular Diagnostics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.